Skip to content
banner-news_01

Group News

  • Tragic passing of Riaan Verster (46)
    on 30.01.2023

    Riaan Verster, Aspen Group Executive: Governance & Communications 1 November 1976 - 28 January 2023 Durban, South Africa - JSE Limited listed Aspen Pharmacare Holdings Limited (APN), regrets to announce the untimely and tragic passing of Riaan Verster, Aspen Group Executive: Governance & Communications, on Saturday 28 January 2023. Riaan regrettably succumbed to his injuries sustained in a motor […]

  • Aspen, CEPI and the Bill & Melinda Gates Foundation expand commitments to improve access to vaccines in Africa
    on 12.12.2022

    New funding supports technology transfer from Serum Institute to Aspen to manufacture routine vaccines in Africa, for Africa Collaboration supports sustainable manufacturing capacity for African-produced vaccines for future epidemics and pandemics Durban, South Africa - JSE Limited listed Aspen Pharmacare Holdings Limited (“Aspen”) a global multinational specialty pharmaceutical company,  announced […]

  • Aspen closes EUR 1,26 billion syndicated loan facilities
    on 08.11.2022

    Durban, South Africa - JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has closed a multi-currency, syndicated term loan and revolving credit facilities agreement. These facilities, totalling circa EUR 1,26 billion equivalent, were put in place to refinance Aspen’s 2018 syndicated loan facilities.  The facilities were structured […]

  • Aspen delivers double digit organic growth in normalised EBITDA, operating profit and earnings
    on 31.08.2022

    Johannesburg – JSE-listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to report reviewed provisional Group financial results for the year ended 30 June 2022. SALIENT FEATURES Revenue from continuing operations increased by 2% (+5% in constant exchange rate (“CER”)) to R38,6 billion (FY2021: R37,8 billion); Normalised EBITDA from continuing […]

  • Aspen concludes a collaboration agreement to manufacture and make available four Aspen-branded vaccines for Africa.
    on 31.08.2022

    Stephen Saad, Aspen Group Chief Executive Durban, South Africa - JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to announce that one of its wholly-owned South African subsidiaries, Aspen SA Operations (Pty) Limited (“Aspen SA Operations”), has concluded a ten-year agreement (“the Agreement”) with Serum Institute of […]

Scroll To Top